Algorithm-driven high-throughput screening of colloidal nanoparticles under simulated physiological and therapeutic

Ashwinkumar A Bhirde1, Sivasish Sindiri2, Gina N Calco3

  • 1Laboratory of Biological Chemistry, Division of Biotechnology Review and Research IV, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Serge.Beaucage@fda.hhs.gov Ashwinkumar.Bhirde@fda.hhs.gov.

Nanoscale
|January 28, 2017
PubMed
Summary

Developing new algorithms for nanoparticle size measurement accelerates stability assessments for cancer drug delivery. This high-throughput method rapidly evaluates nanoparticle behavior under physiological conditions, crucial for clinical translation.

Related Concept Videos